Navigation Links
Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies
Date:4/21/2009

- Preclinical Studies Highlight the Ability of PS-Targeting Antibodies to Reverse the Immune Suppressing Effects of Tumors by Changing the Tumor Microenvironment and Mobilizing Key Components of the Immune System -

- Studies Confirm Peregrine's PS-Targeting Antibodies Stimulate Dendritic Cell Maturation, Inflammatory Cytokine and Chemokine Release and Recruitment of Macrophages to Tumors -

DENVER and TUSTIN, Calif., April 21 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and serious virus infections, today reported that two preclinical studies presented during the AACR 100th Annual Meeting 2009 provided further confirmation of the immunomodulatory mechanisms contributing to the anti-tumor activity of its phosphatidylserine (PS)-targeting antibodies. One study confirms the anti-tumor effects and immune stimulating ability of a fully human anti-PS antibody and the other demonstrates the ability of a second fully human anti-PS antibody to stimulate development of a critical component of the adaptive immune system.

These human PS-targeting antibodies, which are currently being evaluated for both anti-cancer and anti-viral applications, increase the number of product candidates in Peregrine's anti-PS pipeline. Peregrine's lead anti-PS antibody bavituximab is currently in Phase II clinical trials in advanced breast and lung cancers.

"These preclinical studies further elucidate the unique immunomodulatory mechanisms contributing to the observed anti-tumor activity of anti-PS antibodies in preclinical and clinical studies," said Dr. Philip Thorpe, professor of pharmacology at UT Southwestern Medical Center in Dallas, a scientific advisor to Peregrine and co-author of one
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
2. Alimera Sciences Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout
3. Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
4. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
5. Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia.
6. Studies Show Combination Laser Therapy Effective At Clearing Acne, Reducing Oil Production
7. Prescient Medical Achieves Milestones in Clinical Studies of vProtect(TM) Luminal Shield
8. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
9. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
10. Oridion Announces Significant Medical Studies Presented at STA
11. Takeda Initiates Two Phase III Studies with Vedolizumab (MLN0002) in Patients with Inflammatory Bowel Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... -- Sysmex America, Inc., a global leader in medical diagnostic ... exhibit booth during the American Association for Clinical ... in Chicago , July 27 through ... excited to exhibit at AACC this year, because it,s ... continue the dialogue on how to best meet the ...
(Date:7/29/2014)... Mass., July 29, 2014 Cynosure, Inc. ... markets laser- and light-based aesthetic treatment systems for high-volume ... ended June 30, 2014. Second-quarter 2014 financial results incorporate ... on June 24, 2013. Second-Quarter ... increased 45% to $72.6 million , Non-GAAP net ...
(Date:7/29/2014)... -- Apex Medical Corporation (Apex, TWSE: 4106), a leading player ... that it is appealing the judgment of the Regional Court ... that found the headgear of certain mask models ... invalidity challenges against various ResMed patents in major countries. Apex ... junk patents. ResMed filed the lawsuit with ...
Breaking Medicine Technology:New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago 2New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago 3Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12Apex Continues Fighting Against Patents to Free Up Competition 2
... Oct. 9 Vical Incorporated,(Nasdaq: VICL ) ... mice demonstrated,the potential of its patented Vaxfectin(TM) adjuvant ... protein-based H5N1 pandemic influenza vaccine,currently stockpiled by the ... limited vaccine supplies to protect the greatest,number of ...
... Oct. 9 The Wellion Linus Blood Glucose,Monitoring ... recently received certification by the Netherlands Organization,for Applied ... group,founded in 1932 that thoroughly tests and inspects ... the CE Marking. "Receiving the TNO approval ...
Cached Medicine Technology:Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 2Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 3Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant 4WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests 2
(Date:7/29/2014)... California (PRWEB) July 29, 2014 A ... Sciences Professor Doug Ethell, PhD, has developed a blood ... earlier detection and the development of Alzheimer’s disease interventions, ... “Alzheimer’s disease is a puzzle, and this study represents ... for us over the past couple of years,” Ethell ...
(Date:7/29/2014)... July 29, 2014 Most people want to ... younger and feel better about their appearance. There are ... too in Asheville, NC that can help them to look ... salon specializing in result oriented anti-aging procedures that are noninvasive ... problem so many have with cellulite. To accommodate, they ...
(Date:7/29/2014)... way to cure most cases of cancer is to ... approach, however, is that the surgeon may fail to ... , With a new technique, researchers at the University ... surgeons see the entire tumor in the patient, increasing ... on an injectable dye that accumulates in cancerous tissues ...
(Date:7/29/2014)... The report, “Heat Transfer Fluids Market by Type ... & Others), by Application (Oil & Gas, Chemical, CSP, ... & Forecasts to 2019” defines and segments the global ... of the global consumption in terms of volume and ... spread through 199 page sand in-depth TOC on"Heat Transfer ...
(Date:7/29/2014)... As testosterone treatment lawsuits ( http://www.injurybeacon.com/testosterone-androgel/lawsuit/ ... LLP notes that a new study is questioning the ... diabetes. The research, which was published online by The ... involved 88 men who suffered from Type 2 diabetes, ... symptoms and erectile dysfunction. Roughly half of the study ...
Breaking Medicine News(10 mins):Health News:Professor Develops Blood Test for Alzheimer’s Disease Risk 2Health News:Supreme Skin Announces Plans for a Grand Re-opening for Their Noninvasive Anti Aging Microcurrent Face and Body Treatments In Asheville, NC 2Health News:Penn team makes cancer glow to improve surgical outcomes 2Health News:Penn team makes cancer glow to improve surgical outcomes 3Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 2Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 3Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 4Health News:As Testosterone Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Questioning Effectiveness of Low Testosterone Therapy in Diabetics 2Health News:As Testosterone Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Questioning Effectiveness of Low Testosterone Therapy in Diabetics 3Health News:As Testosterone Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Questioning Effectiveness of Low Testosterone Therapy in Diabetics 4
... of Minnesota cancer surgeon and researcher has found a ... the earliest stage of breast cancer choosing to have ... prophylactic mastectomy (CPM) surgery among U.S. women with ductal ... 1998 and 2005, according to Todd Tuttle, M.D., lead ...
... out and destroys tumor cells, researchers say , , FRIDAY, ... virus can target and kill breast cancer stem cells, ... be effective against cancer stem cells, because we have ... cancer cells," Dr. Patrick Lee, a cancer researcher at ...
... Case Timer Solves Widespread ProblemST. LOUIS, April 10 There ... and children are the fastest growing segment. The contact ... growing under those lenses. , , ... fusarium keratitis and acanthamoeba keratitis. These are nasty words ...
... has been promoted to the position of Service Area ... Baron Center, Inc (BCI). Dr. Tau is a ... forensic psychology. Dr. Tau is an expert in assessing ... has been extensively used as a workplace violence and ...
... [Brown University] Nursing homes serving primarily Hispanic ... whose patients were mostly white, according to Brown ... Journal of the American Medical Directors Association ... at the rate of bed sores at nursing ...
... and critical care specialists at Johns Hopkins have begun to ... intensive care unit (ICU) that leads so many patients to ... study reported online April 10 in Critical Care Medicine ... depression six months after hospitalization among very sick ICU patients, ...
Cached Medicine News:Health News:More women with early stage breast cancer choosing double mastectomies 2Health News:Harmless Virus May Be Deadly to Breast Cancer 2Health News:70% of Contact Lens Cases are Contaminated and Nearly 1 in 4 are Never Replaced - a Serious Problem Eye Doctors Want Fixed, WatchDog Group Reports 2Health News:70% of Contact Lens Cases are Contaminated and Nearly 1 in 4 are Never Replaced - a Serious Problem Eye Doctors Want Fixed, WatchDog Group Reports 3Health News:Manny Tau, Psy.D. Promoted to Service Area Leader for the Problematic Behaviors Service Area at Baron Center, Inc 2Health News:Hispanics appear to face poorer quality nursing home care 2Health News:In the ICU, use of benzodiazepines, other factors may predict severity of post-stay depression 2
High-quality eyecare from the preferred name in diagnostic instruments....
Our 2.5v Streak Retinoscope Sets feature instruments with bright light, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Medicine Products: